中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Issue 9
Sep.  2016
Turn off MathJax
Article Contents

Clinical features of chronic HBV/HCV infection complicated by mild hepatic steatosis

DOI: 10.3969/j.issn.1001-5256.2016.09.016
Research funding:

 

  • Published Date: 2016-09-20
  • Objective To investigate the clinical features of previously untreated patients with chronic HBV/HCV infection complicated by mild hepatic steatosis. Methods A total of 111 previously untreated patients with chronic HBV/HCV infection who were hospitalized in Zhengzhou University People's Hospital from December 2014 to January 2016. Liver biopsy confirmed that all the patients had mild hepatic steatosis. Among these patients,65 had HBV infection and 46 had HCV infection. The changes in clinical indices such as liver function,blood lipid,blood glucose,and liver stiffness measurement( LSM) were compared between the two groups. The independent samples t- test or Wilcoxon two- sample test was used for comparison of continuous data between groups,and the chi- square test was used for comparison of categorical data between groups. Results There were significant differences in LSM,aspartate aminotransferase( AST),gamma- glutamyl transpeptidase( GGT),plasma albumin( Alb),total cholesterol( TC),high- density lipoprotein cholesterol( HDL- C),low- density lipoprotein cholesterol( LDL- C),and platelet count( PLT) between the two groups( all P < 0. 05). According to liver inflammation grade and fibrosis stage,the patients were divided into G < 2/S < 2 group( 0,0- 1,1,1- 2) and G≥2/S≥2 group( 2,2- 3,3- 4,4). LSM showed significant differences across the groups with different liver inflammation grades and fibrosis stages( HBV infection: 6. 40( 5. 30 ~ 7. 70) vs 8. 30( 5. 90 ~ 11. 30),Z =- 2. 463,P = 0. 014; 6. 70( 5. 30 ~ 7. 80) vs 8. 30( 5. 70 ~ 11. 30),Z =- 2. 049,P = 0. 040。HCV infection: 7. 60( 6. 30 ~ 11. 50) vs 17. 50( 12. 00 ~ 26. 70),Z =- 3. 961,P < 0. 001; 7. 60( 5. 90 ~ 10. 20) vs 15. 50( 7. 50 ~ 21. 50),Z =- 3. 325,P = 0. 001). In the patients with chronic HCV infection,TC showed a significant difference between the groups with different fibrosis stages( 4. 28 ± 0. 85 vs 3. 82 ± 0. 68,t = 2. 045,P = 0. 047). Conclusion Compared with the previously untreated patients with chronic HBV infection complicated by mild hepatic steatosis,those with HCV infection complicated by mild hepatic steatosis have higher LSM,GGT,TC,and LDL- C,as well as lower Alb,PLT,AST,and HDL- C. In addition,the parameters associated with hepatic steatosis( BMI,GLU,fat attenuation parameter,blood lipid) are not positively correlated with disease progression.

     

  • loading
  • [1]HSU CS,LIU WL,KAO JH,et al.Adipocytokines and liver fibrosis stages in patients with chronic hepatitis B virus infection[J].Hepatol Int,2015,9(2):231-242.
    [2]CHALASANI N,YOUNOSSI Z,LAVINE JE,et al.The diagnosis and management of non-alcoholic fatty liver disease:practice guideline by the American Association for the Study of Liver Diseases,American College of Gastroenterology,and the American Gastroenterological Association[J].Hepatology,2012,55(6):2005-2023.
    [3]CHEN CL,YANG WS,YANG HI,et al.Plasma adipokines and risk of hepatocellular carcinoma in chronic hepatitis B virus-infected carriers:a prospective study in taiwan[J].Cancer Epidemiol Biomarkers Prev,2014,23(8):1659-1671.
    [4]ARANO T,NAKAGAWA H,TATEISHI R,et al.Serum level of adiponectin and the risk of liver cancer development in chronic hepatitis C patients[J].Int J Cancer,2011,129(9):2226-2235.
    [5] Chinese Society of Hepatology,Chinese Society of Infections Diseases,Chinese Medical Association.The guideline of prevention and treatment for chronic hepatitis B(2010 version)[J].Chin J Intern Med,2011,50(2):168-179.(in Chinese)中华医学会肝病学分会,中学医学会感染病学分会.慢性乙型肝炎防治指南(2010版)[J].中华内科杂志,2011,50(2):168-179.
    [6]Chinese Society of Hepatology and Chinese Society of Infectious Diseases and Parasitology,Chinese Medical Association.Guidelines for prevention and treatment of hepatitis C[J].Natl Med J China,2004,84(9):775-780.(in Chinese)中华医学会肝病学分会、传染病与寄生虫病学分会.丙型肝炎防治指南[J].中华医学杂志,2004,84(9):775-780.
    [7]LEMOINE M,RATZIU V,KIM M,et al.Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease[J].Liver Int,2009,29(9):1431-1438.
    [8]KHATTAB MA,ESLAM M,ALY MM,et al.Association of serum adipocytokines with insulin resistance and liver injury in patients with chronic hepatitis C genotype 4[J].J Clin Gastroenterol,2012,46(10):871-879.
    [9]HUI CK,ZHANG HY,LEE NP,et al.Serum adiponectin is increased in advancing liver fibrosis and declines with reduction in fibrosis in chronic hepatitis B[J].J Hepatol,2007,47(2):191-202.
    [10]WONG VW,WONG GL,YU J,et al.Interaction of adipokines and hepatitis B virus on histological liver injury in the Chinese[J].Am J Gastroenterol,2010,105(1):132-138.
    [11]ERKAN G,YILMAZ G,CENGIZ M,et al.Lack of association of hepatic estrogen receptor-alpha expression with histopathological and biochemical findings in chronic hepatitis C[J].Pathol Res Pract,2013,24(5):993-998.
    [12]WANG XY,CHENG SY.Hepatitis C virus detection method[J].Chinese J Exp Clin Virol,2011,25(2):158-161.(in Chinese)王晓艳,陈斯勇.丙型肝炎病毒的病毒学检测方法[J].中华实验和临床病毒学杂志,2011,25(2):158-161.
    [13]KIM KH,SHIN HJ,KIM K,et al.Hepatitis B virus X protein induces hepatic steatosis via transcripyional activation of SREBP 1 and PPAR gamma[J].Gastroenterology,2007,132(5):1955-1967.
    [14]LEE DH,JACOBS DR Jr,GROSS M,et al.Serum gamma-glutamyltransferase was differently associated with microalbuminuria by status of hypertension or diabetes:the Coronary ArteryRisk Development in Young Adults(CARDIA)Study[J].Clin Chem,2005,51(7):1185-1191.
    [15]RYU S,CHANG Y,KIM DI,et al.Gamma-glutamyltransferase as a predictor of chronic kidney disease in nonhypertensive and nondiabetic Korean men[J].Clin Chem,2007,53(1):71-77.
    [16]BANDERAS DZ,ESCOBEDO J,GONZALEZ E,et al.γ-glutamyl transferase:a marker of nonalcoholic fatty liver disease in patients with the meta-bolic syndrome[J].Eur J Gastroenterol Hepatol,2012,24(7):805-810.
    [17]PUOTI C,GUARISCO R,BELLIS L,et al.Diagnosis,management,and treatment of hepatitis C[J].Hepatology,2009,50(1):322-325.
    [18]MA ZZ,LU LG.Nonalcoholic fatty liver disease and liver cirrhosis[J].J Prac Hepatol,2016,19(2):135-138.(in Chinese)马振增,陆伦根.非酒精性脂肪性肝病与肝硬化[J].实用肝脏病杂志,2016,19(2):135-138.
    [19]WAI CT,GREENSON JK,FONTANA R,et al.A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C[J].Hepatology,2003,38(2):518-526.
    [20] SCOTT DR,LEVY MT.Liver transient elastography(Fibroscan):aplace in the management algorithms of chronic vifal hepatitis[J].Antivir ther,2010,15(1):1-11.
    [21]SHAHEEN AA,WAN AF,MYERS RP.Fibrotest and Fibroscan for the prediction of hepatitis C related fibrosis:a systematic review of diagnostic test accuracy[J].Am J Gastroenterol,2007,102(11):2589-2600.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (2493) PDF downloads(453) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return